See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2018_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 103,544,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 69,000 |
| 3 | remainder_Assets | 634,000 |
| 4 | LiabilitiesCurrent | 16,310,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,990,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,387,000 |
| 9 | ResearchAndDevelopmentExpense | 18,938,000 |
| 10 | remainder_Expenses | 1,080,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,848,000 |
| 13 | remainder_ComprehensiveNetIncome | -43,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 104,247,000 |
| 1 | Liabilities | 19,300,000 |
| 2 | Expenses | 32,405,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 84,947,000 |
| 5 | NetIncome | -27,557,000 |
| 6 | ComprehensiveNetIncome | -27,578,500 |
| 7 | BaseVar | 80,421,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.55 |
| 9 | EconomicCapitalRatio | 3.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
